Similar articles

• [Dilzem - a new calcium antagonist is introduced].

  Bohl E. Bohl E. ZFA (Stuttgart). 1982 Feb 20;58(5):292-6. ZFA (Stuttgart). 1982. PMID: 7080650 German. No abstract available.
• Calcium-channel blocking agents.

  Leonard RG, Talbert RL. Leonard RG, et al. Clin Pharm. 1982 Jan-Feb;1(1):17-33. Clin Pharm. 1982. PMID: 6764159 Review.
• Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.

  Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A. Millard RW, et al. Circ Res. 1983 Feb;52(2 Pt 2):I29-39. Circ Res. 1983. PMID: 6831652
• Calcium antagonism--with special reference to diltiazem.

  Kendall MJ, Okopski JV. Kendall MJ, et al. J Clin Hosp Pharm. 1986 Jun;11(3):159-74. doi: 10.1111/j.1365-2710.1986.tb00841.x. J Clin Hosp Pharm. 1986. PMID: 3528227 Review. No abstract available.
• Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.

  Hamm CW, Opie LH. Hamm CW, et al. Circ Res. 1983 Feb;52(2 Pt 2):I129-38. Circ Res. 1983. PMID: 6831647 No abstract available.